EYEN - שווי פירמה כולל eyenovia.com
The market trend for Eyenovia, Inc. (EYEN) demonstrates an Enterprise Value of . The business relies on certified partners to ensure the seamless production of micro-dispensers within sterile zones. Eyenovia, Inc. (EYEN) maintains strong pricing power due to its patents on mist-based drug delivery technology. Meanwhile, demand for glaucoma therapy remains stable, rendering the company resilient to economic fluctuations and market cycles.
Eyenovia (EYEN) - פילוחי מדדים ודוחות פיננסיים
Enterprise Value (EV) sums market capitalization and net debt, determining the actual cost of acquiring a business while accounting for all liabilities and liquidity. The current total market valuation of Eyenovia, Inc. (EYEN) stands at , which, for a biopharmaceutical startup with outsourced production and a minimal environmental footprint, reflects the investment appeal of its intellectual property without the burden of heavy capital assets.